Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Committee for Orphan Medicinal Products at the European Medicines Agency (EMA) has adopted a positive opinion recommending ...
European regulators recommended that a skin disease treatment developed by Vanda Pharmaceuticals receive orphan drug designation. Vanda said Thursday that the European Medicines Agency's Committee for ...
Vanda Pharma cash could be depleted by the end of 2027; multiple pipeline bets heighten both risk and opportunity. Read my ...
Principal Technologies Inc. (the "Company") announces that, further to its news releases dated April 28, 2025, July 28, 2025, and July 31, 2025, regarding the financing of its Licence of Technology ...
Detailed price information for Vanda Pharmaceuticals (VNDA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results